GlobalData on MSN12h
Sanofi’s combo vaccines gain FDA fast track designation
The candidates merge two existing vaccines that have demonstrated favourable tolerability through randomised controlled ...
Hosted on MSN1d
FDA Grants Fast Track Tag to SNY's Two COVID & Flu Vaccine Candidates
Sanofi SNY announced that the FDA has granted a Fast Track designation to two combination vaccine candidates to prevent ...
Monroe County's Sanofi plant fast-tracked for combination COVID/flu vaccine approval
The US Food and Drug Administration(FDA) has granted Fast Track designation to two non-mRNA combination vaccine candidates ...
Press Release: Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US
Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the USFirst non-mRNA combination ...
Pharmabiz17h
US FDA grants fast track designation to two Sanofi’s combination vaccine candidates to prevent influenza & Covid-19 infections
US FDA grants fast track designation to two Sanofi’s combination vaccine candidates to prevent influenza & Covid-19 infections: Paris Thursday, December 12, 2024, 10:00 Hrs [IST ...
Daily1d
Two Sanofi combination vaccine candidates for prevention of influenza, COVID gets USFDA Fast Track designation
Paris: The US Food and Drug Administration (USFDA) has granted Fast Track designation to two Sanofi combination vaccine ...
Medscape4d
Rilzabrutinib Shines in Phase 3 Trial of Tough-to-Treat Immune Thrombocytopenia
The oral BTK inhibitor rilzabrutinib led to rapid and durable platelet responses, reduced bleeding, and improved fatigue in ...
FierceBiotech7d
Sanofi-backed Nuvig marches lead autoimmune therapy into phase 2 with $161M series B
Big Pharma-backed immunomodulation biotech Nuvig Therapeutics is moving its lead asset into phase 2 trials using a $161 ...
BioSpace7d
Nuvig Ropes in $161M Series B From Big Pharma Players for Autoimmune Indications
California-based biotech Nuvig Therapeutics scooped up $161 million from the investment arms of Sanofi, Bayer, Novo Holdings, ...
PharmiWeb1d
Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US
The US Food and Drug Administration has granted Fast Track designation to two Sanofi combination vaccine candidates to prevent influenza and COVID-19 infections in individuals 50 years of age and ...
Sanofi: Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US
Two combination vaccine candidates for prevention of influenza and COVID-19 granted Fast Track designation in the US First non-mRNA combination vaccine candidates that include two already licensed ...